Whatever happened to Reducto, was very promising 12-15 months ago
Yeah that's what we're realising in building pharma specific solutions for clients, high quality eval dataset and automated evals integrated in the CI/CD process seem to be the differentiators
Whatever happened to Reducto, was very promising 12-15 months ago
Yeah that's what we're realising in building pharma specific solutions for clients, high quality eval dataset and automated evals integrated in the CI/CD process seem to be the differentiators